Medtronic plc will present new data on its Symplicity Spyral renal denervation system at the Cardiovascular Research Technologies $(CRT)$ 2026 annual meeting in Washington, D.C., including a late-breaking pooled 36-month analysis from the SPYRAL HTN Clinical Program. The meeting runs March 7–10, 2026, with Medtronic presentations scheduled for March 7, March 9, and March 10. Event-related materials in the document: http://www.medtronic.com/, https://www.linkedin.com/company/medtronic.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief on March 05, 2026, and is solely responsible for the information contained therein.